http://www.youtube.com/watch?v=M5YJgVUMG5M
This interview excerpt covers a lot of ground with Steve Parkinson, CEO of Lakewood Amedex, who reveals how an accidental discovery of a new class of antimicrobial compounds could revolutionize the treatment of chronic diseases, treat myriad infection types and relieve human suffering.
In the course of my routine research, focusing on new therapeutics for biofilm infections, I found this company's technology promising. In the lab, their new class of antimicrobials actually penetrates biofilms and kills microbes in their quiescent state. Clinical trials will prove that out in humans, starting with topical applications.
Let’s all hope and pray that these products get into the clinical environment soon!
